Polymorphisms of glutathione-S-transferase M1 and T1 and prostate cancer risk in a Tunisian population

Cancer Epidemiology

Volumn 34, Issue 5, 2010, Pages 598-603

  Souiden, Yousra ^a,b   Mahdouani, Manel ^a   Chaieb, Kamel ^b   Elkamel, Rafick ^a   Mahdouani, Kacem ^a,b  

^a Hospital of Ibn Eljazzar of Kairouan   (Tunisia)

^b UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

Genetic polymorphism; Glutathione S transferase; GSTM1; GSTT1; Prostate cancer; Tunisian population

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; XENOBIOTIC AGENT;

ADULT; ARTICLE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DETOXIFICATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; TUNISIA;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; SMOKING; TUNISIA;

EID: 77957287518     PISSN: 18777821     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canep.2010.06.002     Document Type: Article

References (74)

1. ACS Cancer facts and figures 2004, American Cancer Society, Atlanta, GA.
2. Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2000: cancer incidence, mortality and prevalence worldwide. Version 1.0. Lyon: IARC Press, ; 2001. http://www.iarc.fr/globocan/globocan.html.
3. Kronz J.D., Silberman M.A., Allsbrook W.C., Bastacky S.I., Burks R.T., Cina S.J., et al. Pathology resident's use of web-based tutorial to improve Gleason grading of prostate carcinoma on needle biopsies. Hum Pathol 2000, 31:1044-1050.
4. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., et al. Cancer statistics, 2006. CA-Cancer J Clin 2006, 56(2):106-130.
5. Greenlee R.T., Hill-Harmon M.B., Murray T., Thun M Cancer statistics, 2001. CA-Cancer J Clin 2001, 51(1):15-36.
6. Nadler R., Humphrey P., Smith D., Catalona W., Ratliff T. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate-specific antigen levels. J Urol 1995, 154:407-413.
7. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
8. North A.B., South CD Cancer Incidence in Antartica (1998-2002). Cancer Incidence in Five Continents 2007, vol. IX. IARC, Lyon, [574 IARC Scientific Publications No. 160].
9. Hsing A., Tsao L., Devesa S. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 2000, 85:60-67.
10. Mayer F., Bairati I., Shadmani R., Fradet Y., Moore L. Dietary fat and prostate cancer survival. Eur Urol 1999, 10:245-251.
11. Hayes J.D., Pulford D.J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995, 30(6):445-600.
12. Strange R.C., Jones P.W., Fryer A.A. Glutathione-S-transferase: genetics and role in toxicology. Toxicol Lett 2000, (112-113):357-363.
13. Srivastava D.S., Mandhani A., Mittal B., Mittal R.D. Genetic polymorphism of glutathione S-transferase genes (GSTT1 and GSTM1 and GSTP1) and susceptibility to prostate cancer in Northern India. BJU Int 2005, 95:170-173.
14. Pearson W.R., Vorachek W.R., Xu S.J., Berger R., Hart I., Vannais D., et al. Identification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13. Am J Hum Genet 1993, 53:220-233.
15. Seidegard J., Vorachek W.R., Pero R.W., Pearson W.R. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 1988, 85:7293-7297.
16. Webb G., Vaska V., Coggan M., Board P. Chromosomal localization of the gene for the human u class glutathione transferase (GSTT1). Genomics 1996, 33:121-123.
17. Pemble S., Schroeder K.R., Spencer S.R., Meyer D.J., Hallier E., Bolt H.M., et al. Human glutathione S-transferase θ (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994, 300(1):271-276.
18. Silig Y., Pinarbasi H., Gunes S., Ayan S., Bagci H., Cetinkaya O. Polymorphisms of CYP1A1, GSTM1, GSTT1 and prostate cancer risk in Turkish population. Cancer Invest 2006, 24:41-45.
19. Ketterer B., Christodoulides L.G. Enzymology of cytosolic glutathione S transferases. Adv Pharmacol 1994, 27:37-69.
20. Rebbeck T.R. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997, 6:733-743.
21. Abdel-Rahman S.Z., Anwar W.A., Abdel-Aal W.E., Mostafa H.M., Au W.W. GSTM1 and GSTT1 genes are potential risk modifiers of bladder cancer. Cancer Detect Prevent 1998, 22:129-138.
22. Dekant W., Vamvakas S. Glutathione dependent bioactivation of xenobiotics. Xenobiotica 1993, 23:873-887.
23. Steinhoff C., Frank K.H., Golka K., Thier R., Römer H.C., Rötzel C., et al. Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma. Arch Toxicol 2000, 74:521-526.
24. Nakazato H., Suzuki K., Matsui H., Koike H., Okugi H., Ohtake N., et al. Association of genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population. Anticancer Res 2003, 23:2897-2902.
25. Medeiros R., Vasconcelos A., Costa S., Pinto D., Ferreira P., Lobo F., et al. Metabolic susceptibility genes and prostate cancer risk in a southern European population: The role of glutathione S-transferases GSTM1, GSTM3, and GSTT1 genetic polymorphisms. Prostate 2004, 58:414-420.
26. Kote-Jarai Z., Easton D., Edwards S.M., Jefferies S., Durocher F., Jackson R.A., et al. Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer. Pharmacogenetics 2001, 1:325-330.
27. Garte S., Gaspari L., Alexandrie A.K., Ambrosone C., Autrup J.L., Baranova H., et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 2001, 10:1239-1248.
28. Chen C.L., Liu Q., Relling M.V. Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics 1996, 6:187-191.
29. Arand M., Muhlbaur R., Hengstler J., Jager E., Fuchs J., Winkler L., et al. A multiplex polymerase chain reaction protocol for simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal Biochem 1996, 236:384-386.
30. Cotton S.C., Sharp L., Little J., Brockton N. Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol 2000, 151:7-32.
31. Geisler S.A., Olshan A.F. GSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: a mini-HuGE review. Am J Epidemiol 2001, 154:95-105.
32. Rebbeck T.R., Walker A.H., Jaffe J.M., White D.L., Wein A.J., Malkowicz S.B. Glutathione S-transferase-mu (GSTM1) and -theta (GSTT1) genotypes in the etiology of prostate cancer. Cancer Epidemiol Biomarkers Prev 1999, 8:283-287.
33. Chelbi H., Lachheb J., Ammar J., Hamzaoui K., Hamzaoui A. Association of GST genes polymorphisms with asthma in Tunisian children. Med Infl 2007, 1-6.
34. Bendjemana K., Abdennebi M., Gara S., Jmal A., Ghanem A., Touati S., et al. Polymorphisme génétique des enzymes gluthation-S-transférases et N-acetyl-transférases 2 dans le cancer du nasopharynx en Tunisie. Bull Cancer 2006 Mar 1, 93(3):297-302.
35. Murata M., Shiraishi T., Fukutome K., Watanabe M., Nagao M., Kubota Y., et al. Cytochrome P4501A1 and glutathione S-transferase M1 genotypes as risk factors for prostate cancer in Japan. Jpn J Clin Oncol 1998, 28:657-660.
36. Acevedo C., Opazo J.L., Huidobro C., Cabezas J., Iturrieta J. Quinones Sepulveda L. Positive correlation between single or combined genotypes of CYP1A1 and GSTM1 in relation to prostate cancer in Chilean people. Prostate 2003, 57:111-117.
37. Lai M.T., Chen R.H., Tsai F.J., Wan L., Chen W.C. Glutathione S-transferase M1 gene but not insulin-like growth factor-2 gene or epidermal growth factor gene is associated with prostate cancer. Urol Oncol 2005, 23:225-229.
38. Agalliu I., Langeberg W.J., Lampe J.W., Salinas C.A., Stanford J.L. Glutathione S-transferase M1, T1, and P1 polymorphisms and prostate cancer risk in middle aged men. Prostate 2006, 66:146-156.
39. Ming L., Tong-yu G., Yao L., Yan-qun N. Polymorphisms of GSTM1 and CYP1A1 genes and their genetic susceptibility to prostate cancer in Chinese men. Chinese Med J 2008, 121:305-308.
40. Ansari B.S., Vasudevan R., Mirinargesi M., Patimah I., Sabariah A.R., Pasalar P., et al. Lack of association of glutathione S-transferase gene polymorphisms in iranian prostate cancer subjects. Am J Biochem Biotechnol 2009, 5:30-34.
41. Autrup J.L.C., Thomassen L.H., Olsen J.H., Wolf H., Autrup H. Glutathione-S-transferase as risk factors in prostate cancer. Eur J Cancer Prev 1999, 8:525-532.
42. Gsur A., Haidinger G., Hinteregger S. Polymorphisms of glutathione-S-transferase genes (GSTP1, GSTM1 and GSTT1) and prostate-cancer risk. Int J Cancer 2001, 95:152-155.
43. Murata M., Watanabe M., Yamanaka M., Kubota Y., Ito H., Nagao M., et al. Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population. Cancer Lett 2001, 165:171-177.
44. Lima-Jr M.M., Oliveira M.N., Granja F., Trindade A.C., De Castro Santos L.E., Word L.S. Lack of association of GSTT1, GSTM1, GSTO1, GSTP1 and CYP1A1 polymorphisms for susceptibility and outcome in Brazilian prostate cancer patients. Folia Biol 2008, 54:102-108.
45. Kidd L.C., Woodson K., Taylor P.R., Albanes D., Virtamo J., Tangrea J.A. Polymorphism of glutathione-S-transferase genes (GST-M1, GST-T1 and GST-P1) and susceptibility to prostate cancer among male smokers of the ATBC cancer prevention study. Eur J Cancer Prev 2003, 12:317-320.
46. Bostwick D.G., Burke H.B., Djakiew D., Euling S., Ho S.M., Landolph J., et al. Human prostate cancer risk factors. Cancer 2004, 101:2371-2490.
47. Carter B.S., Beaty T.H., Steinberg G.D., Childs B., Walsh P.C. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 1992, 89:3367-3371.
48. Coughlin S.S., Hall I.J. A review of genetic polymorphisms and prostate cancer risk. Ann Epidemiol 2002, 12:182-196.
49. Nwosu V., Carpten J., Trent J.M., Sheridan R. Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease. Hum Mol Genet 2001, 10:2313-2318.
50. Nock N.L., Liu X., Cicek M.S., Li L., Macarie F., Rybicki B.A., et al. Polymorphisms in polycyclic aromatic hydrocarbon metabolism and conjugation genes, interactions with smoking and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2006, 15:756-761.
51. Kelada S.N., Kardia S.L., Walker A.H., Wein A.J., Malkowicz S.B., Rebbeck T.R. The glutathione S-transferase-mu and -theta genotypes in the etiology of prostate cancer: genotype-environment interactions with smoking. Cancer Epidemiol Biomarkers Prev 2000, 9:1329-1334.
52. Mao G.E., Morris G., Lu Q.Y., Cao W., Reuter V.E., Cordon-Cardo C., et al. Glutathione S-transferase P1 Ile105Val polymorphism, cigarette smoking and prostate cancer. Cancer Detect Prev 2004, 28:368-374.
53. Norppa H. Cytogenetic markers of susceptibility: influence of polymorphic carcinogen-metabolizing enzymes. Environ Health Perspect 1997, 105(4):829-835.
54. Norppa H Influence of genetic enzyme polymorphisms on cytogenetic biomarkers. Human monitoring after environmental and occupational exposure to chemical and physical agents 2000, vol. 313:300-311. IOS Press, Amsterdam, [NATO Science Series, Series A. Life Sciences].
55. Au W.W., Sierra-Torres C.H., Cajas-Salazar N., Salama S.A. Cytogenetic effects from exposure to mixed pesticides and the influence from genetic susceptibility. Environ Health Perspect 1999, 107:501-505.
56. Pavanello S., Clonfero E. Biological indicators of genotoxic risk and metabolic polymorphisms. Mutat Res 2000, 463:285-308.
57. Norppa H., Hirvonen A Metabolic polymorphisms of importance in biomonitoring. Human monitoring after environmental and occupational exposure to chemical and physical agents 2000, vol. 313:289-299. IOS Press, Amsterdam, [NATO Science Series, Series A: Life Sciences].
58. Norppa H. Genetic polymorphisms and chromosome damage. Int J Hyg Environ Health 2001, 204:31-38.
59. Bell D.A., Taylor J.A., Paulson D.F., Robertson C.N., Mohler J.L., Lucier G.W. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 1993, 85:1159-1164.
60. Brockmoller J., Cascorbi I., Kerb R., Roots I. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res 1996, 56:3915-3925.
61. Reszka E., Wasowicz W. Genetic polymorphism of N-acetyltransferase and glutathione S-transferase related to neoplasm of genitourinary system. Neoplasma 2002, 49:209-216.
62. Keshava C., McCanlies E.C., Weston A. CYP3A4 polymorphisms-potential risk factors for breast and prostate cancer: a HuGE review. Am J Epidemiol 2004, 160:825-841.
63. Maugard C.M., Charrier J., Pitard A., Campion L., Akande O., Ali-Osman F. Genetic polymorphism at the glutathione-S-transferase (GST) P1 locus is a breast cancer risk modifier. Int J Cancer 2001, 91:334-339.
64. Seidegard J., Pero R.W., Markowiz M.M., Roush G., Miller D.G., Beattie J. Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer. Carcinogenesis 1990, 11:33-36.
65. Nazar-Stewart V., Motulsky A/G, Eaton D.L., White E., Hornung S.K., Weiss N.S. The glutathione S-transferase m polymorphism as a marker for the susceptibility to lung cancer. Cancer Res 1993, 53:2313-2318.
66. Hirvonen A., Husgafvel-Pursiainen K., Anttila S., Vainio H. The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis 1993, 14:1479-1481.
67. Chen H.W., Sandler D.P., Taylor A., Shore D.L., Liu E., Bell D.A. Increased risk for myelodysplastic syndromes in individuals with glutathione-transferase theta 1 (GSTT1) gene defect. Lancet 1996, 347:295-297.
68. Perera F.P. Environment and cancer: who are susceptible?. Science 1997, 278:1068-1073.
69. Mittal R.D., Srivastava D.S.L., Mandhani A., Kumar A., Mittal B. Polymorphism of GSTM1 and GSTT1 genes in prostate cancer: a study from North India. Ind J Cancer 2004, 41:115-119.
70. Hsing A.W., McLaughlin J.K., Schuman L.M., Bjelker E., Gridley G., Wacholder S., et al. Diet, tobacco use, and fatal prostate cancer: results from a Lutheran Brotherhood Cohort Study. Cancer Res 1990, 50:6836-6840.
71. Lumey H. Prostate cancer and smoking: a review of case-control and cohort studies. Prostate 1996, 29:249-260.
72. Lotufo P.A., Lee I.M., Ajani U.A., Hennekens C.H., Mason J.E. Cigarette smoking and risk of prostate cancer in the physicians' health study (United States). Int J Cancer 2000, 87:141-144.
73. Katoh T., Inatomi H., Kim H., Yang M., Matsumoto T., Kawamoto T. Effects of glutathione S-transferases GSTM1 and GSTT1 genotypes on urothelial cancer risk. Cancer Lett 1998, 132:147-152.
74. Merrick G.S., Butler W.M., Wallner K.E., Galbreath R.W., Lief J.H., Adamovich E. Effect of cigarette smoking on biochemical outcome after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2004, 58:1056-1062.